How can oncology teams navigate USP <800> requirements for hazardous drugs?

For oncology settings where hazardous drugs and antineoplastic medications are part of daily practice, maintaining safe handling processes requires a clear understanding of USP <800> and the latest NIOSH hazardous drug guidance.

For oncology settings where hazardous drugs and antineoplastic medications are part of daily practice, maintaining safe handling processes requires a clear understanding of USP <800> and the latest NIOSH hazardous drug guidance. 

Key takeaways

  • Understand the latest hazardous drug guidance and what changes to the NIOSH List may mean for your organization.
  • Evaluate Assessment of Risk considerations with a decision pathway to help determine whether a hazardous drug requires full containment or may qualify for an Assessment of Risk.
  • Support safer handling practices for hazardous drugs across oncology pharmacy workflows.

Strengthen hazardous drug safety in your oncology practice

Complete the form below to access "From list to practice: A Pharmacist's roadmap to USP <800> and the updated NIOSH List".
Simplifi 797 Video Thumbnail Web Hero

Simplifi 797®

Support safer, consistent compliance in oncology pharmacy. Simplifi 797® helps teams manage USP <800> and other pharmacy compliance requirements with automated tasks, real-time tracking, reporting, and audit-ready documentation.

Expert Insights

Back To Top